Obesity and Multiple Myeloma: What Do the Data Tell Us?Rafael Rios Tamayo1,2*, Juan Sáinz Perez1,2, Jose Juan Jimenez-Moleon3,4 and Manuel Jurado Chacon1,2
- Corresponding Author:
- Rafael Rios
Monoclonal Gammopathies Unit University Hospital Virgen de las Nieves
Granada, Spain, Genomic Oncology Area
Genyo (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research)
Tel: +34 671592298
Fax: +34 958020655
E-mail: [email protected]
Received Date: May 02, 2014; Accepted Date: May 04, 2014; Published Date: May 06, 2014
Citation: Tamayo RR, Perez JS, Jimenez-Moleon JJ, Chaconv MJ (2014) Obesity and Multiple Myeloma: What Do the Data Tell Us? J Leuk (Los Angel) 2:e109. doi:10.4172/2329-6917.1000e109
Copyright: © 2014 Tamayo RR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Obesity is a major public health problem throughout the world. It is defined as an excess accumulation of adipose tissue, which is considered as a heterogeneous and highly active endocrine and metabolic organ.